Search Results - "Jones, Jon W"

Refine Results
  1. 1

    Successful Hand Transplantation — One-Year Follow-up by Jones, Jon W, Gruber, Scott A, Barker, John H, Breidenbach, Warren C

    Published in The New England journal of medicine (17-08-2000)
    “…In 1996, the Louisville Hand Transplant Team was formed to examine the possibility of performing a human hand transplantation. One of our first goals was to…”
    Get full text
    Journal Article
  2. 2

    Ex-vivo study of flow dynamics and endothelial cell structure during extended hypothermic machine perfusion preservation of livers by Jain, Shailendra, Xu, Hongzhi, Duncan, Heather, Jones, Jon W., Zhang, Jian X., Clemens, Mark G., Lee, Charles Y.

    Published in Cryobiology (01-06-2004)
    “…Liver transplantation is often the only effective treatment for end stage liver diseases resulting from cirrhosis, hepatitis, progressive jaundice, and biliary…”
    Get full text
    Journal Article
  3. 3

    Survival transplantation of preserved non-heart-beating donor rat livers: Preservation by hypothermic machine perfusion by LEE, Charles Y, SHAILENDRA JAIN, DUNCAN, Heather M, ZHANG, Jian X, STONES, Jon W, SOUTHARD, James H, CLEMENS, Mark G

    Published in Transplantation (27-11-2003)
    “…Non-heart-beating donor (NHBD) livers are an untapped source with the potential to provide relief to the current donor shortage problem. Hypothermic machine…”
    Get full text
    Journal Article
  4. 4

    Functional recovery of preserved livers following warm ischemia: Improvement by machine perfusion preservation by LEE, Charles Y, ZHANG, Jian X, JONES, Jon W, SOUTHARD, James H, CLEMENS, Mark G

    Published in Transplantation (15-10-2002)
    “…Hypothermic machine perfusion preservation has the potential to relieve the current donor shortage problem by reclaiming and preserving marginal donor organs…”
    Get full text
    Journal Article
  5. 5

    Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies by Gorantla, Vijay S., Barker, John H., Jones Jr, Jon W., Prabhune, Kaustubha, Maldonado, Claudio, Granger, Darla K.

    Published in Microsurgery (2000)
    “…Over the past century, the concept of interfering with the immune response at various sites by blocking the formation, stimulation, proliferation, and…”
    Get full text
    Journal Article
  6. 6

    Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand by GRANGER, Darla K, BRIEDENBACH, Warren C, PIDWELL, Diane J, JONES, Jon W, BAXTER-LOWE, Lee Ann, KAUFMAN, Christina L

    Published in Transplantation (15-12-2002)
    “…Composite tissue allografts offer great potential in reconstructive surgery. However, the risks of immunosuppression and graft-versus-host disease (GVHD) after…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Successful Hand Transplantation — One-Year Follow-up by Cooney, W P, Hentz, V R

    Published in The New England journal of medicine (04-01-2001)
    “…To the Editor: Jones et al. (Aug. 17 issue) 1 describe transplantation of a hand and provide one year of follow-up data on the recipient. Although one can…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetic advantage of intra-arterial cyclosporin A delivery to vascularly isolated rabbit forelimb. I. Model development by Shirbacheh, M V, Ren, X, Jones, J W, Breidenbach, W C, Jevans, A W, Fernandez-Botran, G R, Maldonado, C, Barker, J H, Gruber, S A

    “…Effective antirejection therapy with minimal systemic morbidity is required if limb transplantation is to become a clinical reality. We investigated whether…”
    Get more information
    Journal Article
  10. 10

    Pharmacokinetics of intra-arterial delivery of tacrolimus to vascularly isolated rabbit forelimb by Shirbacheh, M V, Jones, J W, Harralson, T A, Edelstein, J, Tecimer, T, Breidenbach, W C, Jevans, A W, Maldonado, C, Barker, J H, Gruber, S A

    “…A vascularly isolated rabbit forelimb model simulating conditions of composite tissue allografting was used to determine the regional pharmacokinetic advantage…”
    Get more information
    Journal Article
  11. 11

    Osteomyocutaneous flap as a preclinical composite tissue allograft: Swine model by Ren, Xiaoping, Shirbacheh, Mansour V., Üstüner, E. Tuncay, Zdichavsky, Marty, Edelstein, Jean, Maldonado, Claudio, Breidenbach, Warren C., Frank, Johannes, Tobin, Gordon R., Jones, Jon W., Barker, John H.

    Published in Microsurgery (2000)
    “…Composite tissue allotransplantation (CTA) constitutes one of the last frontiers of microsurgery. Prior to its clinical application, the long‐term efficacy of…”
    Get full text
    Journal Article
  12. 12

    Pharmacokinetic advantage of intra-arterial cyclosporin A delivery to vascularly isolated rabbit forelimb. II. Dose dependence by Shirbacheh, M V, Harralson, T A, Jones, J W, Breidenbach, W C, Jevans, A W, Maldonado, C, Barker, J H, Gruber, S A

    “…A vascularly isolated rabbit forelimb model simulating conditions of composite tissue allografting was used to determine the regional pharmacokinetic advantage…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapy by Jones, Jon W., Üstüner, E.Tuncay, Zdichavsky, Marty, Edelstein, Jean, Ren, Xiaoping, Maldonado, Claudio, Ray, Mokunda, Jevans, Anthony W., Breidenbach, Warren C., Gruber, Scott A., Barker, John H.

    Published in Surgery (01-08-1999)
    “…Background: High-dose tacrolimus (FK506) monotherapy has significantly prolonged rat hindlimb allograft survival. With an eye toward direct clinical…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Long-term composite tissue allograft survival in a porcine model with cyclosporine/mycophenolate mofetil therapy by ÜSTÜNER, E. T, ZDICHAVSKY, M, JONES, J. W, XIAOPING REN, EDELSTEIN, J, MALDONADO, C, RAY, M, JEVANS, A. W, BREIDENBACH, W. C, GRUBER, S. A, BARKER, J. H

    Published in Transplantation (27-12-1998)
    “…Low-dose cyclosporine (CsA)/mycophenolate mofetil (MMF) therapy has significantly reduced the frequency of rejection and drug-induced side effects in rat…”
    Get full text
    Conference Proceeding Journal Article
  17. 17
  18. 18
  19. 19
  20. 20